Transcatheter Mitral Valve Interventions: Current Therapies and Future Directions.

about

Preface: innovations in the management of valvular and structural heart disease.Review of Diagnostic and Therapeutic Approach to Canine Myxomatous Mitral Valve Disease.Current Status and Future Direction of Transcatheter Mitral Valve Replacement.

P2860

Q40985759-F70C7168-DBAA-4291-BC0E-4F88505207ED Q45070678-68C02E07-5366-41FE-AEA6-9B9C2C80FB32 Q55001762-6A9346F4-1023-47D5-9FDF-5D16967C621E

P2860

Transcatheter Mitral Valve Interventions: Current Therapies and Future Directions.

Item

http://www.wikidata.org/entity/Q38736848

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Transcatheter Mitral Valve Interventions: Current Therapies and Future Directions.

@en

type

Item

label

Transcatheter Mitral Valve Interventions: Current Therapies and Future Directions.

@en

prefLabel

Transcatheter Mitral Valve Interventions: Current Therapies and Future Directions.

@en

P1476

Transcatheter Mitral Valve Interventions: Current Therapies and Future Directions.

@en

P2093

Ramon A Partida

http://www.w3.org/2001/XMLSchema#string

P2860

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

Percutaneous approaches to valve repair for mitral regurgitation

2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Initial Experience With Commercial Transcatheter Mitral Valve Repair in the United States.

Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation: 5-Year Results of EVEREST II.

Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repair.

Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: results of the EVEREST II study.

Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation.

Anatomy of the mitral valvular complex and its implications for transcatheter interventions for mitral regurgitation.

Transcatheter implantation of the MONARC coronary sinus device for mitral regurgitation: 1-year results from the EVOLUTION phase I study (Clinical Evaluation of the Edwards Lifesciences Percutaneous Mitral Annuloplasty System for the Treatment of Mi

P2888

s11936-017-0538-2

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11936-017-0538-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sammy Elmariah

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28364394

http://www.w3.org/2001/XMLSchema#string

Transcatheter Mitral Valve Interventions: Current Therapies and Future Directions.

about

P2860

P2860

Transcatheter Mitral Valve Interventions: Current Therapies and Future Directions.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698